Cerebrospinal fluid markers of inflammation and infections in schizophrenia and affective disorders: a systematic review and meta-analysis

Antidepressants are cytotoxic to rat primary blood brain barrier endothelial cells at high therapeutic concentrations

(2017) Ekramy Elmorsy et al.   TOXICOLOGY IN VITRO

Elevated C-reactive protein and late-onset bipolar disorder in 78 809 individuals from the general population

(2016) Marie Kim Wium-Andersen et al.   BRITISH JOURNAL OF PSYCHIATRY

Evidence of cerebrospinal fluid abnormalities in patients with depressive syndromes

(2016) Dominique Endres et al.   JOURNAL OF AFFECTIVE DISORDERS

In vivo markers of inflammatory response in recent-onset schizophrenia: a combined study using [11C]DPA-713 PET and analysis of CSF and plasma

(2016) J M Coughlin et al.   Translational Psychiatry

Increased cerebrospinal fluid interleukin-8 in bipolar disorder patients associated with lithium and antipsychotic treatment

(2015) Anniella Isgren et al.   BRAIN BEHAVIOR AND IMMUNITY

IgG dynamics of dietary antigens point to cerebrospinal fluid barrier or flow dysfunction in first-episode schizophrenia

(2015) Emily G. Severance et al.   BRAIN BEHAVIOR AND IMMUNITY

Cumulative meta-analysis of interleukins 6 and 1β, tumour necrosis factor α and C-reactive protein in patients with major depressive disorder

(2015) Rita Haapakoski et al.   BRAIN BEHAVIOR AND IMMUNITY

Immunological findings in psychotic syndromes: a tertiary care hospital's CSF sample of 180 patients

(2015) Dominique Endres et al.   Frontiers in Human Neuroscience

Low IL-8 is associated with anxiety in suicidal patients: genetic variation and decreased protein levels

(2014) S. Janelidze et al.   ACTA PSYCHIATRICA SCANDINAVICA

An observational study of inflammation in the central nervous system in patients with bipolar disorder

(2014) Oliver Stich et al.   BIPOLAR DISORDERS

Higher CSF interleukin-6 and CSF interleukin-8 in current depression in older women. Results from a population-based sample

(2014) Silke Kern et al.   BRAIN BEHAVIOR AND IMMUNITY

Elevation of cerebrospinal fluid interleukin-1β in bipolar disorder

(2014) Johan Söderlund et al.   JOURNAL OF PSYCHIATRY & NEUROSCIENCE

Biological insights from 108 schizophrenia-associated genetic loci

(2014)   NATURE

Blood–cerebrospinal fluid barrier dysfunction in patients with bipolar disorder in relation to antipsychotic treatment

(2014) Henrik Zetterberg et al.   PSYCHIATRY RESEARCH

Inflammatory Molecular Signature Associated With Infectious Agents in Psychosis

(2014) Lindsay N. Hayes et al.   SCHIZOPHRENIA BULLETIN

Association of Serum Interleukin 6 and C-Reactive Protein in Childhood With Depression and Psychosis in Young Adult Life

(2014) Golam M. Khandaker et al.   JAMA Psychiatry

Effect of Anti-inflammatory Treatment on Depression, Depressive Symptoms, and Adverse Effects

(2014) Ole Köhler et al.   JAMA Psychiatry

The association between depressive symptoms, cognitive function, and inflammation in major depression

(2013) Jesper Krogh et al.   BRAIN BEHAVIOR AND IMMUNITY

Increased cerebrospinal fluid interleukin-6 levels in patients with schizophrenia and those with major depressive disorder

(2013) Daimei Sasayama et al.   JOURNAL OF PSYCHIATRIC RESEARCH

Autoimmune Diseases and Severe Infections as Risk Factors for Mood Disorders

(2013) Michael E. Benros et al.   JAMA Psychiatry

Autoimmune diseases and infections as risk factors for schizophrenia

(2012) Michael E. Benros et al.   Annals of the New York Academy of Sciences

Fluoxetine inhibits matrix metalloprotease activation and prevents disruption of blood–spinal cord barrier after spinal cord injury

(2012) Jee Y. Lee et al.   BRAIN

Cerebrospinal fluid and lumbar puncture: a practical review

(2012) Ben L. C. Wright et al.   JOURNAL OF NEUROLOGY

Marked reduction of soluble superoxide dismutase-1 (SOD1) in cerebrospinal fluid of patients with recent-onset schizophrenia

(2012) J M Coughlin et al.   MOLECULAR PSYCHIATRY

Altered chemokine levels in the cerebrospinal fluid and plasma of suicide attempters

(2012) Shorena Janelidze et al.   PSYCHONEUROENDOCRINOLOGY

Meta-Analysis of Cytokine Alterations in Schizophrenia: Clinical Status and Antipsychotic Effects

(2011) Brian J. Miller et al.   BIOLOGICAL PSYCHIATRY

PROINFLAMMATORY AND “RESILIENCY” PROTEINS IN THE CSF OF PATIENTS WITH MAJOR DEPRESSION

(2011) Jose M. Martinez et al.   DEPRESSION AND ANXIETY

Cerebrospinal fluid diagnostics in first-episode schizophrenia

(2011) Laura Kranaster et al.   EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE

Role of cytokines in atypical depression

(2011) Ho-Kyoung Yoon et al.   NORDIC JOURNAL OF PSYCHIATRY

Infectious agents associated with schizophrenia: A meta-analysis

(2011) Isabel Arias et al.   SCHIZOPHRENIA RESEARCH

Autoimmune diseases, bipolar disorder, and non-affective psychosis

(2010) William W Eaton et al.   BIPOLAR DISORDERS

Interleukin-6 Is Elevated in the Cerebrospinal Fluid of Suicide Attempters and Related to Symptom Severity

(2009) Daniel Lindqvist et al.   BIOLOGICAL PSYCHIATRY

A Meta-Analysis of Cytokines in Major Depression

(2009) Yekta Dowlati et al.   BIOLOGICAL PSYCHIATRY

Monoamines, BDNF, IL-6 and corticosterone in CSF in patients with Parkinson’s disease and major depression

(2009) Sven Pålhagen et al.   JOURNAL OF NEUROLOGY

Cerebrospinal fluid analysis in affective and schizophrenic spectrum disorders: Identification of subgroups with immune responses and blood–CSF barrier dysfunction

(2009) K. Bechter et al.   JOURNAL OF PSYCHIATRIC RESEARCH

Activation of brain interleukin-1β in schizophrenia

(2009) J Söderlund et al.   MOLECULAR PSYCHIATRY

Associations of Depression With C-Reactive Protein, IL-1, and IL-6: A Meta-Analysis

(2009) M Bryant Howren et al.   PSYCHOSOMATIC MEDICINE

Inflammatory Cytokine Alterations in Schizophrenia: A Systematic Quantitative Review

(2007) Stéphane Potvin et al.   BIOLOGICAL PSYCHIATRY